首页> 外国专利> Upper motor neurones corticospinal, Methods and compositions for Differentiating neural stem cells by modulating the Signaling of the CB1 cannabinoid receptor and Uses Thereof

Upper motor neurones corticospinal, Methods and compositions for Differentiating neural stem cells by modulating the Signaling of the CB1 cannabinoid receptor and Uses Thereof

机译:上运动神经元皮质脊髓,通过调节CB1大麻素受体的信号来分化神经干细胞的方法和组合物及其用途

摘要

In vitro method for obtain a higher corticospinal motor Neuron from a neural stem cell.The said method comprises contacting a neural stem cell in appropriate conditions to increase the signal mediated by the CB1 cannabinoid receptor in the cell and conditionS to promote the dorsalizaciu00f3n this cell and the appropriate conditions to increase the signal mediated by the CB1 cannabinoid receptor implies an increase in the number of cells CTISATB2 P2 + - with regard to basal levels of at least 5% and involve: (i) contacting Said cell with a neural cannabinoid CB1 receptor agonist selected GroupConsists of anandamide and 2-arachidonoylglycerol (2-ag), N - or arachidonyl ethanolamide dopamine, - 2 '- cloroetilamida (ACEA), Hu - 210, jwh-073, WIN 55212 - 2, cannabinol, tetrahydrocannabinol (THC),11 Hydroxy (- Oh? 9 - 11 - tetrahydrocannabinol THC), levonantradol, dronabinol, am-2201 (1 - (5 - fluoropentil) - 3 - (1 - naftoil) indole), jwh-018 (1 - pentyl - 3 - (1 - naftoil) indole), AM - 678,2 - (2 - age or arachidonyl glyceryl ether, ether noladina), Palmitoiletanolamida (PEA) and CP 55940; and / or (ii) introduce a neural stem cell in the expression vector encoding the CB1 cannabinoid receptor to increase expression of the cannabinoid receptor CB1 above itS basal levels.And / or (iii) introduce a neural stem cell in the expression vector that encodes an enzyme Synthesis of endocannabinoids in the cell to increase the activity of an enzyme SynthesisEndocannabinoids above basal levels.And / or (iv) make this a neural stem cell is an agent that endocannabinoid degradation Enzyme is selected from the group consisting of a Plasmid, a arnip,A ribozyme and antisense nucleic acid and / or contacting Said cell with a neural inhibitor the Enzyme degradation of endocannabinoids.And the conditions for Promoting the dorsalizaciu00f3n that involve contacting Said cell with a neural Stem Cell dorsalizaciu00f3n Agent selected from: (a) an inhibitor of SoniC Hedgehog selected from the group consisting of 3 ', 5' - cyclic monophosphate sodium salt of N6 '- -, O2 dibutyryl adenosine, ay 9944, cyclopamine KAAD cyclopamine -, forskolin, gant58, gant61, jk184,HPI HPI - 1, - 3, - 1 jervina, Sant robotnikinina 0449 -, GDC, and IPI - 926; and (b) a Smad inhibitor selected from the group consisting nogina, dorsomorfina, sb431542, LDN - 193189, Lefty, Activin,TGF beta and combinations thereof.
机译:从神经干细胞获得更高的皮质脊髓运动神经元的体外方法。所述方法包括在适当条件下使神经干细胞接触,以增加细胞中CB1大麻素受体介导的信号,并促进S.salizazaci u00f3n。细胞和增加CB1大麻素受体介导的信号的适当条件意味着至少基础水平的5%会增加CTISATB2 P2 +-细胞的数量,并且涉及:(i)使所述细胞与神经大麻素接触CB1受体激动剂选择的组包括阿南酰胺和2-花生四烯酸甘油酯(2-ag),N-或花生四烯酸乙醇酰胺多巴胺,-2'-cloroetilamida(ACEA),Hu- 210,jwh-073,WIN 55212-2,大麻酚,四氢大麻酚( THC),11羟基(-哦?9-11-四氢大麻酚THC),左苯二酚,屈大麻酚,am-2201(1-(5--氟戊基)-3-(1--萘酚)吲哚),jwh-018(1-戊基-3-(1-萘甲酚)吲哚,AM-6 78,2-(2--年龄或花生四烯酸甘油醚,noladina醚),Palmitoiletanolamida(PEA)和CP 55940;和/或(ii)在编码CB1大麻素受体的表达载体中引入神经干细胞,以将大麻素受体CB1的表达增加到基础水平以上;和//(iii)在表达载体中引入神经干细胞编码细胞中内源性大麻素的酶的合成以增加酶的合成内源性大麻素的活性至基础水平以上。和/或(iv)使它成为神经干细胞是内源性大麻素降解的试剂。酶选自质粒,arnip,核酶和反义核酸,和/或使所述细胞与神经抑制剂接触,从而降解内源性大麻素。促进dosalizacici的条件包括使所述细胞与神经干细胞dorsalizaci / u00f3n接触。选自以下的药剂:(a)SoniC Hedgehog抑制剂,选自N6'-的3',5'-环状单磷酸钠盐,O2二丁酰腺苷, ay 9944,环巴胺KAAD环巴胺-,福司可林,gant58,gant61,jk184,HPI HPI-1,-3,-1 jervina,Sant robotnikinina 0449-,GDC,和IPI-926; (b)Smad抑制剂,选自nogina,dorsomorfina,sb431542,LDN-193189,Lefty,Activin,TGFβ及其组合。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号